In Vitro Diagnostics
Venue: Crowne Plaza St James Hotel
|Event Date/Time: Jul 12, 2010||End Date/Time: Jul 13, 2010|
|Early Registration Date: Mar 31, 2010|
"The global IVD market has shown a consistent growth of 6.72 percent annually,
a trend that is expected to continue until 2012."
This conference will provide an integral forum to leaders in biotech, pharma and labs to discuss the value of diagnostics and overcome challenges posed by regulatory bodies. Make sure you attend this event and walk away with all the essential knowledge needed to maximise the potential, profitability and sustainability of your business.
Key Speakers Include:
â€¢ Ansar Jawaid, Global Diagnostics Manager, ASTRAZENECA
â€¢ Dr Said El Mouatassim, Head of Molecular Biology, BIOMNIS SPECIALISED MEDICAL PATHOLOGY
â€¢ Vicki Petrides, Statistician Section Head, Diagnostics Division, ABBOTT DIAGNOSTICS
â€¢ Elaine Mooney, Scientific Officer IVD, IRISH MEDICINES BOARD
â€¢ Anil Modak, Associate Director, Medical Products Research & Development, CAMBRIDGE ISOTOPE LABORATORIES
â€¢ Dr Rob Elles, Director of Molecular Genetics, MANCHESTER ACADEMIC HEALTH SCIENCE CENTRE, ST MARYâ€™S HOSPITAL
Key Topics Include:
â€¢ Delivering on the promise of personalised healthcare
â€¢ Understanding the role and impact of new technologies in point of care testing
â€¢ Molecular tests for drug resistance and genotyping
â€¢ Opportunities for new biochip technology in laboratory & point of care testing
â€¢ IVD industry guidelines, study design and analysis considerations
Plus a half-day post-conference workshop:
Development of IVD SMEs. What are the business models and are they viable?
Wednesday 14th July, Crowne Plaza St James Hotel, London
In association with Molecular Detection Inc
For a full programme visit our website, www.smi-online.co.uk/2010ivd18.asp.
Sponsorship and Exhibition Opportunities are available
To find out more contact Alia Malick - Head of Pharmaceuticals
On tel: +44 (0)20 7827 6168 or email: email@example.com